CD8A and lung carcinoma: Specifically, PGRN expression by CD8+ T cells from peripheral blood mononuclear cells (PBMCs) was significantly higher in lung cancer patients compared to healthy individuals, whereas CCL3 levels were significantly reduced (Supplementary Fig. S6).